🇺🇸 FDA
Patent

US 12227554

Methods for selectively expanding cells expressing a TCR with a murine constant region

granted A61KA61K2239/28A61K40/11

Quick answer

US patent 12227554 (Methods for selectively expanding cells expressing a TCR with a murine constant region) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2239/28, A61K40/11, A61K40/32, A61K40/4205